Tessa Therapeutics Pte Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Tessa Therapeutics Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013402
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tessa Therapeutics Pte Ltd (Tessa Therapeutics) is a clinical-stage biotechnology company that develops and commercializes cancer immunotherapies that redirect the body’s powerful anti-viral immune response to identify and exterminate cancer cells. The company provides products for various cancers including nasopharyngeal, gastric carcinoma, cervical, oropharyngeal, lung, head and neck cancer. It harnesses virus-specific T cell (VST) technology for the treatment of solid tumors. Tessa Therapeutics is also extending its VST platform to treat an array of solid tumors through combinatorial approaches with antibodies, chimeric antigen receptors, and oncolytic virus technologies. The company works in partnership with National Cancer Centre, Singapore; Baylor College of Medicine; and Agency for Science, Technology and Research. Tessa Therapeutics is headquartered in Singapore.

Tessa Therapeutics Pte Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Agreement 10
Tessa Therapeutics and Vyriad Enter into Agreement 11
Tessa Therapeutics Enters into Agreement with Institute of Molecular and Cell Biology 12
Tessa Therapeutics Enters into Co-Development Agreement with Baylor Medical College 13
National Cancer Centre Singapore and Tessa Therapeutics Expand Research Agreement 14
Licensing Agreements 15
Tessa Therapeutics Enters into Licensing Agreement with Baylor College of Medicine 15
Acquisition 16
Tessa Therapeutics Acquires Euchloe Bio 16
Tessa Therapeutics Pte Ltd – Key Competitors 17
Tessa Therapeutics Pte Ltd – Key Employees 18
Tessa Therapeutics Pte Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Jul 20, 2017: Tessa Therapeutics Appoints Ms. Jennifer Butler as Chief Commercial Officer 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tessa Therapeutics Pte Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Agreement 10
Tessa Therapeutics and Vyriad Enter into Agreement 11
Tessa Therapeutics Enters into Agreement with Institute of Molecular and Cell Biology 12
Tessa Therapeutics Enters into Co-Development Agreement with Baylor Medical College 13
National Cancer Centre Singapore and Tessa Therapeutics Expand Research Agreement 14
Tessa Therapeutics Enters into Licensing Agreement with Baylor College of Medicine 15
Tessa Therapeutics Acquires Euchloe Bio 16
Tessa Therapeutics Pte Ltd, Key Competitors 17
Tessa Therapeutics Pte Ltd, Key Employees 18
Tessa Therapeutics Pte Ltd, Subsidiaries 19

★海外企業調査レポート[Tessa Therapeutics Pte Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hyundai Motor Company:企業の戦略・SWOT・財務分析
    Hyundai Motor Company - Strategy, SWOT and Corporate Finance Report Summary Hyundai Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Williams Companies, Inc.:企業の戦略・SWOT・財務分析
    The Williams Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Williams Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (FDZJ), a subsidiary of Shanghai Pharmaceutical Co Ltd, is a bio-pharmaceutical company that develops, manufactures and markets genetic engineering drugs. The company offers bio-pharmaceutical products in the field of genetic engineering, p …
  • SurModics Inc (SRDX):企業の財務・戦略的SWOT分析
    SurModics Inc (SRDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Oncolys BioPharma Inc (4588)-製薬・医療分野:企業M&A・提携分析
    Summary Oncolys BioPharma Inc (Oncolys) is a biotechnology company that discovers, and develops treatments for cancer and infectious diseases. The company imports and exports oncolytic viruses, drugs and medicines, and tumor diagnostic agents. Its pharmaceutical pipeline products include OBP-301, OB …
  • Foodwell Corporation:企業の戦略・SWOT・財務分析
    Foodwell Corporation - Strategy, SWOT and Corporate Finance Report Summary Foodwell Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sharp HealthCare:企業の戦略的SWOT分析
    Sharp HealthCare - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Kyushu Electric Power Company, Incorporated:企業の戦略・SWOT・財務分析
    Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Eli Lilly and Company:企業のM&A・事業提携・投資動向
    Eli Lilly and Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eli Lilly and Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Neptune Technology Group Inc:企業の戦略的SWOT分析
    Neptune Technology Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Alliqua BioMedical Inc (ALQA)-医療機器分野:企業M&A・提携分析
    Summary Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s product categories include ultrasound healing therapy, human biologics, antimicrobial …
  • Bureau Veritas SA:企業の戦略・SWOT・財務分析
    Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report Summary Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ICL Group Ltd (ICL):企業の財務・戦略的SWOT分析
    ICL Group Ltd (ICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Premier Farnell Ltd:企業の戦略的SWOT分析
    Premier Farnell Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • DaVita Inc (DVA)-医療機器分野:企業M&A・提携分析
    Summary DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company is a provider of dialysis services in the US for patients with chronic kidney failure and end-stage renal disease (ESRD). …
  • F&C Investment Trust PLC:企業の戦略・SWOT・財務分析
    F&C Investment Trust PLC - Strategy, SWOT and Corporate Finance Report Summary F&C Investment Trust PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Willis Lease Finance Corp (WLFC):企業の財務・戦略的SWOT分析
    Willis Lease Finance Corp (WLFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Digital Locations Inc (CABN):企業の財務・戦略的SWOT分析
    Summary Digital Locations Inc (Digital Locations), is a provider of software solutions. It is a developer of cell tower sites for the 5G revolution. The company's 5G wireless networks provide applications include the Internet of things (IOT), self-driving cars, real-time hologram-based collaboration …
  • Troms Offshore Supply AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Troms Offshore Supply AS (Troms Offshore), a subsidiary of Tidewater Inc, is a offshore service provider that owns and operates offshore service vessels and other special vessels related to research and sub sea activities. The company’s fleet includes platform supply vessels, polar research …
  • IREN SpA (IRE):電力:M&Aディール及び事業提携情報
    Summary IREN SpA (IREN) is a multi-utility. It generates and sells electricity and thermal energy; sells gas; collects, selects, recovers and disposes urban waste; and provides integrated water services, and public lighting, global services and other services. The company produces power in hydro, th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆